Addex and Merck & Co online pharmacy.
Addex and Merck & Co online pharmacy . Are working together develop drugs develop drugs for Parkinson’s diseaseAllosteric modulation company company Addex Pharmaceuticals announced that it has an exclusive collaboration and license agreement with Merck & Co. Merck with the goal of developing a new class of orally available drugs. Originally as candidates for the treatment of Parkinson’s disease and possibly other indications silent The partners will discover and positive allosteric modulators develop specifically the metabotropic glutamate receptor 4 . The deal includes lead mGluR4 PAMs discovered by Addex. – ‘We are proud to have founded this collaboration with Merck because their researchers have helped potential potential of targeting mGluR4 to treat Parkinson’s disease, ‘Vincent Mutel, CEO of Addex, ‘This is another important confirmation of our leadership in allosteric modulation. ‘.
Harland Medical Systems is specialized in the development of automated modules that can be linked together in different configurations to handle a variety of coatings applications. Harland says, this modular approach offers OEMs a cost effective alternative to outsourcing a custom coating system or an in-house manufacturing. (more…)